The present invention relates to the use of de novo ceramide synthesis pathway inhibitors, particularly myriocin , to treat cardiac reperfusion injury.
Methods for treating cardiac reperfusion injury
Luigi Anastasia
2017-01-01
Abstract
The present invention relates to the use of de novo ceramide synthesis pathway inhibitors, particularly myriocin , to treat cardiac reperfusion injury.File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
